Company Overview and News

 
LafargeHolcim's (HCMLY) CEO Jan Jenisch on Q1 2018 Results - Earnings Call Transcript

2018-05-12 seekingalpha
Ladies and gentlemen, good morning. Welcome to the LafargeHolcim Q1 2018 Results Conference Call. I'm Cher, the Chorus Call operator. [Operator Instructions] The conference must not be recorded for publication or broadcast.

 
LAFARGEHOLCIM LTD ADR 2018 Q1 - Results - Earnings Call Slides

2018-05-12 seekingalpha
The following slide deck was published by LAFARGEHOLCIM LTD ADR in conjunction with their 2018 Q1 earnings call.

 
Sensex loses 261 pts in 2 straight sessions after hitting 3-month high; PC Jeweller up 44%

2018-05-04 moneycontrol
Profit booking and weak Asian cues pulled the market lower for the second consecutive session today after hitting a three-month high Wednesday. ITC, Reliance Industries, Infosys and select banking and financials stocks led the market down.

 
LAFARGEHOLCIM LTD ADR 2017 Q4 - Results - Earnings Call Slides

2018-03-03 seekingalpha
The following slide deck was published by LAFARGEHOLCIM LTD ADR in conjunction with their 2017 Q4 earnings call.

1
Tracking Mason Hawkins' Southeastern Asset Management Portfolio - Q4 2017 Update

2018-02-25 seekingalpha
Mason Hawkins’ 13F portfolio value decreased from $8.32B to $8.08B this quarter. The number of positions increased from 27 to 30.

 
Saddled With Investor Worries, Cemex Deserves Another Look

2018-01-26 seekingalpha
Cemex has underperformed as investors remain worried about Mexico's near-term future and the company's value/market share trade-offs.

1
Tata Motors appoints Hanne Sorensen as independent director

2018-01-03 moneycontrol
Tata Motors today announced appointment of Hanne Birgitte Sorensen, former CEO of Netherlands-based supply chain firm Damco, as an additional and independent director for a tenure of five years.

6
Tracking Mason Hawkins' Southeastern Asset Management Portfolio - Q3 2017 Update

2017-11-23 seekingalpha
Mason Hawkins’ 13F portfolio value decreased from $9.11B to $8.32B this quarter. The number of positions decreased from 28 to 27.

 
Kenya's ARM Is to Become Next Target in Africa Cement Wars - Bloomberg

2017-11-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
CRH: Irish Firm Bets On America

2017-11-09 seekingalpha
The aggregates business is seeing a lot of roll-up consolidation, and CRH is a big driver of that here domestically.

 
LafargeHolcim's (HCMLY) CEO Jan Jenisch on Q3 2017 Results - Earnings Call Transcript

2017-10-29 seekingalpha
Ladies and gentlemen, good morning. Welcome to the Q3 2017 Results Analyst Conference Call. I'm Milo [ph], the Chorus Call operator. I would like to remind you that all participants will be in listen-only mode and the conference is being recorded. [Operator Instructions] The conference must not be recorded for publication or broadcast.

 
Aliko Dangote Ups Bidding War for PPC With Cash, Share Offer - Bloomberg

2017-09-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
CRH to Buy Ash Grove in $3.5 Billion Deal to Bulk Up in U.S. - Bloomberg

2017-09-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Dangote Is Said to Mull Offer for PPC as Bidding War Looms - Bloomberg

2017-09-08 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
LAFARGEHOLCIM LTD ADR 2017 Q2 - Results - Earnings Call Slides

2017-07-29 seekingalpha
The following slide deck was published by LAFARGEHOLCIM LTD ADR in conjunction with their 2017 Q2 earnings call.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 50586V108